 | • レポートコード：D0GIR-01012 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、次世代抗体治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。次世代抗体治療の種類別市場規模（抗体薬物複合体（ADC）、二重特異性抗体（BsAbs）、Fc改変抗体、抗体断片・抗体様タンパク質（AF・ALP）、バイオシミラー抗体（Ab）製品）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer、Biogen、Amgen、Roche、Takeda Pharmaceuticals、Bristol-Myers Squibb、ImmunoGen、Bayer、AstraZeneca、Seattle Genetics、Kyowa Hakko Kirin、Xencor、Dyax Corp ・地域別グローバル市場分析 2015年-2020年 ・次世代抗体治療の北米市場（アメリカ、カナダ、メキシコ） ・次世代抗体治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・次世代抗体治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・次世代抗体治療の南米市場（ブラジル、アルゼンチン） ・次世代抗体治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：抗体薬物複合体（ADC）、二重特異性抗体（BsAbs）、Fc改変抗体、抗体断片・抗体様タンパク質（AF・ALP）、バイオシミラー抗体（Ab）製品 ・用途別分析：病院、クリニック、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Next Generation Antibody Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Next Generation Antibody Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Next Generation Antibody Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Next Generation Antibody Therapeutics market has been segmented into:
Antibody Drug Conjugates (ADCs)
Bispecific Antibodies (BsAbs)
Fc Engineered Antibodies
Antibody Fragments and Antibody-Like Proteins (AF & ALPs)
Biosimilar Antibody (Ab) Products
By Application, Next Generation Antibody Therapeutics has been segmented into:
Hospitals
Clinics
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Next Generation Antibody Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Next Generation Antibody Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Next Generation Antibody Therapeutics market.
The report offers in-depth assessment of the growth and other aspects of the Next Generation Antibody Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Next Generation Antibody Therapeutics Market Share Analysis
Next Generation Antibody Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Next Generation Antibody Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Next Generation Antibody Therapeutics sales, revenue and market share for each player covered in this report.
The major players covered in Next Generation Antibody Therapeutics are:
Pfizer
Biogen
Amgen
Roche
Takeda Pharmaceuticals
Bristol-Myers Squibb
ImmunoGen
Bayer
AstraZeneca
Seattle Genetics
Kyowa Hakko Kirin
Xencor
Dyax Corp
Table of Contents
1 Next Generation Antibody Therapeutics Market Overview
1.1 Product Overview and Scope of Next Generation Antibody Therapeutics
1.2 Classification of Next Generation Antibody Therapeutics by Type
1.2.1 Global Next Generation Antibody Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Next Generation Antibody Therapeutics Revenue Market Share by Type in 2019
1.2.3 Antibody Drug Conjugates (ADCs)
1.2.4 Bispecific Antibodies (BsAbs)
1.2.5 Fc Engineered Antibodies
1.2.6 Antibody Fragments and Antibody-Like Proteins (AF & ALPs)
1.2.7 Biosimilar Antibody (Ab) Products
1.3 Global Next Generation Antibody Therapeutics Market by Application
1.3.1 Overview: Global Next Generation Antibody Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Next Generation Antibody Therapeutics Market by Regions
1.4.1 Global Next Generation Antibody Therapeutics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Next Generation Antibody Therapeutics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Next Generation Antibody Therapeutics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Next Generation Antibody Therapeutics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Next Generation Antibody Therapeutics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Next Generation Antibody Therapeutics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Next Generation Antibody Therapeutics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Next Generation Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Biogen
2.2.1 Biogen Details
2.2.2 Biogen Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Biogen SWOT Analysis
2.2.4 Biogen Product and Services
2.2.5 Biogen Next Generation Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Amgen
2.3.1 Amgen Details
2.3.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Amgen SWOT Analysis
2.3.4 Amgen Product and Services
2.3.5 Amgen Next Generation Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Roche SWOT Analysis
2.4.4 Roche Product and Services
2.4.5 Roche Next Generation Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Takeda Pharmaceuticals
2.5.1 Takeda Pharmaceuticals Details
2.5.2 Takeda Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Takeda Pharmaceuticals SWOT Analysis
2.5.4 Takeda Pharmaceuticals Product and Services
2.5.5 Takeda Pharmaceuticals Next Generation Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bristol-Myers Squibb
2.6.1 Bristol-Myers Squibb Details
2.6.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Bristol-Myers Squibb SWOT Analysis
2.6.4 Bristol-Myers Squibb Product and Services
2.6.5 Bristol-Myers Squibb Next Generation Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.7 ImmunoGen
2.7.1 ImmunoGen Details
2.7.2 ImmunoGen Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 ImmunoGen SWOT Analysis
2.7.4 ImmunoGen Product and Services
2.7.5 ImmunoGen Next Generation Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bayer
2.8.1 Bayer Details
2.8.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Bayer SWOT Analysis
2.8.4 Bayer Product and Services
2.8.5 Bayer Next Generation Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.9 AstraZeneca
2.9.1 AstraZeneca Details
2.9.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 AstraZeneca SWOT Analysis
2.9.4 AstraZeneca Product and Services
2.9.5 AstraZeneca Next Generation Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.10 Seattle Genetics
2.10.1 Seattle Genetics Details
2.10.2 Seattle Genetics Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Seattle Genetics SWOT Analysis
2.10.4 Seattle Genetics Product and Services
2.10.5 Seattle Genetics Next Generation Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.11 Kyowa Hakko Kirin
2.11.1 Kyowa Hakko Kirin Details
2.11.2 Kyowa Hakko Kirin Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Kyowa Hakko Kirin SWOT Analysis
2.11.4 Kyowa Hakko Kirin Product and Services
2.11.5 Kyowa Hakko Kirin Next Generation Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.12 Xencor
2.12.1 Xencor Details
2.12.2 Xencor Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Xencor SWOT Analysis
2.12.4 Xencor Product and Services
2.12.5 Xencor Next Generation Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.13 Dyax Corp
2.13.1 Dyax Corp Details
2.13.2 Dyax Corp Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Dyax Corp SWOT Analysis
2.13.4 Dyax Corp Product and Services
2.13.5 Dyax Corp Next Generation Antibody Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Next Generation Antibody Therapeutics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Next Generation Antibody Therapeutics Players Market Share
3.2.2 Top 10 Next Generation Antibody Therapeutics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Next Generation Antibody Therapeutics Revenue and Market Share by Regions
4.2 North America Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
4.3 Europe Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
4.5 South America Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
5 North America Next Generation Antibody Therapeutics Revenue by Countries
5.1 North America Next Generation Antibody Therapeutics Revenue by Countries (2015-2020)
5.2 USA Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
5.3 Canada Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
5.4 Mexico Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
6 Europe Next Generation Antibody Therapeutics Revenue by Countries
6.1 Europe Next Generation Antibody Therapeutics Revenue by Countries (2015-2020)
6.2 Germany Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
6.3 UK Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
6.4 France Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
6.5 Russia Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
6.6 Italy Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Next Generation Antibody Therapeutics Revenue by Countries
7.1 Asia-Pacific Next Generation Antibody Therapeutics Revenue by Countries (2015-2020)
7.2 China Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
7.3 Japan Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
7.4 Korea Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
7.5 India Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
8 South America Next Generation Antibody Therapeutics Revenue by Countries
8.1 South America Next Generation Antibody Therapeutics Revenue by Countries (2015-2020)
8.2 Brazil Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
8.3 Argentina Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Next Generation Antibody Therapeutics by Countries
9.1 Middle East & Africa Next Generation Antibody Therapeutics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
9.3 UAE Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
9.4 Egypt Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
9.5 South Africa Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Next Generation Antibody Therapeutics Revenue and Market Share by Type (2015-2020)
10.2 Global Next Generation Antibody Therapeutics Market Forecast by Type (2019-2024)
10.3 Antibody Drug Conjugates (ADCs) Revenue Growth Rate (2015-2025)
10.4 Bispecific Antibodies (BsAbs) Revenue Growth Rate (2015-2025)
10.5 Fc Engineered Antibodies Revenue Growth Rate (2015-2025)
10.6 Antibody Fragments and Antibody-Like Proteins (AF & ALPs) Revenue Growth Rate (2015-2025)
10.7 Biosimilar Antibody (Ab) Products Revenue Growth Rate (2015-2025)
11 Global Next Generation Antibody Therapeutics Market Segment by Application
11.1 Global Next Generation Antibody Therapeutics Revenue Market Share by Application (2015-2020)
11.2 Next Generation Antibody Therapeutics Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Next Generation Antibody Therapeutics Market Size Forecast (2021-2025)
12.1 Global Next Generation Antibody Therapeutics Market Size Forecast (2021-2025)
12.2 Global Next Generation Antibody Therapeutics Market Forecast by Regions (2021-2025)
12.3 North America Next Generation Antibody Therapeutics Revenue Market Forecast (2021-2025)
12.4 Europe Next Generation Antibody Therapeutics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Next Generation Antibody Therapeutics Revenue Market Forecast (2021-2025)
12.6 South America Next Generation Antibody Therapeutics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Next Generation Antibody Therapeutics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Next Generation Antibody Therapeutics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Next Generation Antibody Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Next Generation Antibody Therapeutics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Next Generation Antibody Therapeutics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Pfizer Corporate Information, Location and Competitors
Table 6. Pfizer Next Generation Antibody Therapeutics Major Business
Table 7. Pfizer Next Generation Antibody Therapeutics Total Revenue (USD Million) (2017-2018)
Table 8. Pfizer SWOT Analysis
Table 9. Pfizer Next Generation Antibody Therapeutics Product and Solutions
Table 10. Pfizer Next Generation Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Biogen Corporate Information, Location and Competitors
Table 12. Biogen Next Generation Antibody Therapeutics Major Business
Table 13. Biogen Next Generation Antibody Therapeutics Total Revenue (USD Million) (2018-2019)
Table 14. Biogen SWOT Analysis
Table 15. Biogen Next Generation Antibody Therapeutics Product and Solutions
Table 16. Biogen Next Generation Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Amgen Corporate Information, Location and Competitors
Table 18. Amgen Next Generation Antibody Therapeutics Major Business
Table 19. Amgen Next Generation Antibody Therapeutics Total Revenue (USD Million) (2017-2018)
Table 20. Amgen SWOT Analysis
Table 21. Amgen Next Generation Antibody Therapeutics Product and Solutions
Table 22. Amgen Next Generation Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Roche Corporate Information, Location and Competitors
Table 24. Roche Next Generation Antibody Therapeutics Major Business
Table 25. Roche Next Generation Antibody Therapeutics Total Revenue (USD Million) (2017-2018)
Table 26. Roche SWOT Analysis
Table 27. Roche Next Generation Antibody Therapeutics Product and Solutions
Table 28. Roche Next Generation Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Takeda Pharmaceuticals Corporate Information, Location and Competitors
Table 30. Takeda Pharmaceuticals Next Generation Antibody Therapeutics Major Business
Table 31. Takeda Pharmaceuticals Next Generation Antibody Therapeutics Total Revenue (USD Million) (2017-2018)
Table 32. Takeda Pharmaceuticals SWOT Analysis
Table 33. Takeda Pharmaceuticals Next Generation Antibody Therapeutics Product and Solutions
Table 34. Takeda Pharmaceuticals Next Generation Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 36. Bristol-Myers Squibb Next Generation Antibody Therapeutics Major Business
Table 37. Bristol-Myers Squibb Next Generation Antibody Therapeutics Total Revenue (USD Million) (2017-2018)
Table 38. Bristol-Myers Squibb SWOT Analysis
Table 39. Bristol-Myers Squibb Next Generation Antibody Therapeutics Product and Solutions
Table 40. Bristol-Myers Squibb Next Generation Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. ImmunoGen Corporate Information, Location and Competitors
Table 42. ImmunoGen Next Generation Antibody Therapeutics Major Business
Table 43. ImmunoGen Next Generation Antibody Therapeutics Total Revenue (USD Million) (2017-2018)
Table 44. ImmunoGen SWOT Analysis
Table 45. ImmunoGen Next Generation Antibody Therapeutics Product and Solutions
Table 46. ImmunoGen Next Generation Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Bayer Corporate Information, Location and Competitors
Table 48. Bayer Next Generation Antibody Therapeutics Major Business
Table 49. Bayer Next Generation Antibody Therapeutics Total Revenue (USD Million) (2017-2018)
Table 50. Bayer SWOT Analysis
Table 51. Bayer Next Generation Antibody Therapeutics Product and Solutions
Table 52. Bayer Next Generation Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. AstraZeneca Corporate Information, Location and Competitors
Table 54. AstraZeneca Next Generation Antibody Therapeutics Major Business
Table 55. AstraZeneca Next Generation Antibody Therapeutics Total Revenue (USD Million) (2017-2018)
Table 56. AstraZeneca SWOT Analysis
Table 57. AstraZeneca Next Generation Antibody Therapeutics Product and Solutions
Table 58. AstraZeneca Next Generation Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Seattle Genetics Corporate Information, Location and Competitors
Table 60. Seattle Genetics Next Generation Antibody Therapeutics Major Business
Table 61. Seattle Genetics Next Generation Antibody Therapeutics Total Revenue (USD Million) (2017-2018)
Table 62. Seattle Genetics SWOT Analysis
Table 63. Seattle Genetics Next Generation Antibody Therapeutics Product and Solutions
Table 64. Seattle Genetics Next Generation Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Kyowa Hakko Kirin Corporate Information, Location and Competitors
Table 66. Kyowa Hakko Kirin Next Generation Antibody Therapeutics Major Business
Table 67. Kyowa Hakko Kirin Next Generation Antibody Therapeutics Total Revenue (USD Million) (2017-2018)
Table 68. Kyowa Hakko Kirin SWOT Analysis
Table 69. Kyowa Hakko Kirin Next Generation Antibody Therapeutics Product and Solutions
Table 70. Kyowa Hakko Kirin Next Generation Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Xencor Corporate Information, Location and Competitors
Table 72. Xencor Next Generation Antibody Therapeutics Major Business
Table 73. Xencor Next Generation Antibody Therapeutics Total Revenue (USD Million) (2017-2018)
Table 74. Xencor SWOT Analysis
Table 75. Xencor Next Generation Antibody Therapeutics Product and Solutions
Table 76. Xencor Next Generation Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Dyax Corp Corporate Information, Location and Competitors
Table 78. Dyax Corp Next Generation Antibody Therapeutics Major Business
Table 79. Dyax Corp Next Generation Antibody Therapeutics Total Revenue (USD Million) (2017-2018)
Table 80. Dyax Corp SWOT Analysis
Table 81. Dyax Corp Next Generation Antibody Therapeutics Product and Solutions
Table 82. Dyax Corp Next Generation Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Global Next Generation Antibody Therapeutics Revenue (Million USD) by Players (2015-2020)
Table 84. Global Next Generation Antibody Therapeutics Revenue Share by Players (2015-2020)
Table 85. Global Next Generation Antibody Therapeutics Revenue (Million USD) by Regions (2015-2020)
Table 86. Global Next Generation Antibody Therapeutics Revenue Market Share by Regions (2015-2020)
Table 87. North America Next Generation Antibody Therapeutics Revenue by Countries (2015-2020)
Table 88. North America Next Generation Antibody Therapeutics Revenue Market Share by Countries (2015-2020)
Table 89. Europe Next Generation Antibody Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 90. Asia-Pacific Next Generation Antibody Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 91. South America Next Generation Antibody Therapeutics Revenue by Countries (2015-2020)
Table 92. South America Next Generation Antibody Therapeutics Revenue Market Share by Countries (2015-2020)
Table 93. Middle East and Africa Next Generation Antibody Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 94. Middle East and Africa Next Generation Antibody Therapeutics Revenue Market Share by Countries (2015-2020)
Table 95. Global Next Generation Antibody Therapeutics Revenue (Million USD) by Type (2015-2020)
Table 96. Global Next Generation Antibody Therapeutics Revenue Share by Type (2015-2020)
Table 97. Global Next Generation Antibody Therapeutics Revenue Forecast by Type (2021-2025)
Table 98. Global Next Generation Antibody Therapeutics Revenue by Application (2015-2020)
Table 99. Global Next Generation Antibody Therapeutics Revenue Share by Application (2015-2020)
Table 100. Global Next Generation Antibody Therapeutics Revenue Forecast by Application (2021-2025)
Table 101. Global Next Generation Antibody Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Next Generation Antibody Therapeutics Picture
Figure 2. Global Next Generation Antibody Therapeutics Revenue Market Share by Type in 2019
Figure 3. Antibody Drug Conjugates (ADCs) Picture
Figure 4. Bispecific Antibodies (BsAbs) Picture
Figure 5. Fc Engineered Antibodies Picture
Figure 6. Antibody Fragments and Antibody-Like Proteins (AF & ALPs) Picture
Figure 7. Biosimilar Antibody (Ab) Products Picture
Figure 8. Next Generation Antibody Therapeutics Revenue Market Share by Application in 2019
Figure 9. Hospitals Picture
Figure 10. Clinics Picture
Figure 11. Others Picture
Figure 12. Global Next Generation Antibody Therapeutics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Next Generation Antibody Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Next Generation Antibody Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Next Generation Antibody Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Next Generation Antibody Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Next Generation Antibody Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Next Generation Antibody Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Next Generation Antibody Therapeutics Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Next Generation Antibody Therapeutics Revenue Market Share in 2019
Figure 21. Global Top 10 Players Next Generation Antibody Therapeutics Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Next Generation Antibody Therapeutics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Next Generation Antibody Therapeutics Revenue Market Share by Regions (2015-2020)
Figure 25. Global Next Generation Antibody Therapeutics Revenue Market Share by Regions in 2018
Figure 26. North America Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 27. Europe Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 29. South America Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 31. North America Next Generation Antibody Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 32. North America Next Generation Antibody Therapeutics Revenue Market Share by Countries in 2019
Figure 33. USA Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 34. Canada Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 36. Europe Next Generation Antibody Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Next Generation Antibody Therapeutics Revenue Market Share by Countries in 2019
Figure 38. Germany Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 39. UK Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 40. France Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 41. Russia Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 42. Italy Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Next Generation Antibody Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Next Generation Antibody Therapeutics Revenue Market Share by Countries in 2019
Figure 45. China Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 46. Japan Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 47. Korea Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 48. India Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 50. South America Next Generation Antibody Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 51. South America Next Generation Antibody Therapeutics Revenue Market Share by Countries in 2019
Figure 52. Brazil Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Next Generation Antibody Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Next Generation Antibody Therapeutics Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 57. UAE Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Next Generation Antibody Therapeutics Revenue and Growth Rate (2015-2020)
Figure 60. Global Next Generation Antibody Therapeutics Revenue Share by Type (2015-2020)
Figure 61. Global Next Generation Antibody Therapeutics Revenue Share by Type in 2019
Figure 62. Global Next Generation Antibody Therapeutics Market Share Forecast by Type (2021-2025)
Figure 63. Global Antibody Drug Conjugates (ADCs) Revenue Growth Rate (2015-2020)
Figure 64. Global Bispecific Antibodies (BsAbs) Revenue Growth Rate (2015-2020)
Figure 65. Global Fc Engineered Antibodies Revenue Growth Rate (2015-2020)
Figure 66. Global Antibody Fragments and Antibody-Like Proteins (AF & ALPs) Revenue Growth Rate (2015-2020)
Figure 67. Global Biosimilar Antibody (Ab) Products Revenue Growth Rate (2015-2020)
Figure 68. Global Next Generation Antibody Therapeutics Revenue Share by Application (2015-2020)
Figure 69. Global Next Generation Antibody Therapeutics Revenue Share by Application in 2019
Figure 70. Global Next Generation Antibody Therapeutics Market Share Forecast by Application (2021-2025)
Figure 71. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 72. Global Clinics Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Next Generation Antibody Therapeutics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Next Generation Antibody Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Next Generation Antibody Therapeutics Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Next Generation Antibody Therapeutics Revenue Market Forecast (2021-2025)
Figure 78. Europe Next Generation Antibody Therapeutics Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Next Generation Antibody Therapeutics Revenue Market Forecast (2021-2025)
Figure 80. South America Next Generation Antibody Therapeutics Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Next Generation Antibody Therapeutics Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
抗体薬物複合体（ADC）の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Antibody Drug Conjugates (ADCs) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Antibody Drug…- 抗体薬物コンジュゲート治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Antibody Drug Conjugate Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chai…
- 抗体薬物複合体（ADC）薬物の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Antibody Drug Conjugate (ADC) Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain …
- オステオカルシン抗体の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Osteocalcin Antibody market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 狂犬病モノクローナル抗体の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Rabies Monoclonal Antibody market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…